SGT-53 in Children With Recurrent or Progressive CNS Malignancies
Early Phase 1
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2018-06-13
- Last Posted Date
- 2022-02-08
- Lead Sponsor
- SynerGene Therapeutics, Inc.
- Target Recruit Count
- 6
- Registration Number
- NCT03554707
- Locations
- 🇺🇸
Children's National Medical Center, Washington, District of Columbia, United States
A Study of SGT-53 in Children With Refractory or Recurrent Solid Tumors
- First Posted Date
- 2015-02-03
- Last Posted Date
- 2022-02-08
- Lead Sponsor
- SynerGene Therapeutics, Inc.
- Target Recruit Count
- 18
- Registration Number
- NCT02354547
- Locations
- 🇺🇸
Texas Children's Hospital, Houston, Texas, United States
Study of Combined SGT-53 Plus Gemcitabine/Nab-Paclitaxel for Metastatic Pancreatic Cancer
Phase 2
- Conditions
- Interventions
- First Posted Date
- 2015-01-16
- Last Posted Date
- 2022-02-08
- Lead Sponsor
- SynerGene Therapeutics, Inc.
- Target Recruit Count
- 28
- Registration Number
- NCT02340117
- Locations
- 🇺🇸
Mary Crowley Cancer Research Center, Dallas, Texas, United States
Phase II Study of Combined Temozolomide and SGT-53 for Treatment of Recurrent Glioblastoma
- First Posted Date
- 2015-01-16
- Last Posted Date
- 2021-03-03
- Lead Sponsor
- SynerGene Therapeutics, Inc.
- Target Recruit Count
- 1
- Registration Number
- NCT02340156
- Locations
- 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
🇨🇳China Medical University Hospital, Taichung, Taiwan
A Phase I Study of Systemic Gene Therapy With SGT-94 in Patients With Solid Tumors
- First Posted Date
- 2012-01-25
- Last Posted Date
- 2017-04-26
- Lead Sponsor
- SynerGene Therapeutics, Inc.
- Target Recruit Count
- 13
- Registration Number
- NCT01517464
- Locations
- 🇺🇸
University of Texas, M.D. Anderson Cancer Center, Houston, Texas, United States
Safety Study of Infusion of SGT-53 to Treat Solid Tumors
- First Posted Date
- 2007-05-08
- Last Posted Date
- 2017-04-26
- Lead Sponsor
- SynerGene Therapeutics, Inc.
- Target Recruit Count
- 25
- Registration Number
- NCT00470613
- Locations
- 🇺🇸
Mary Crowley Medical Research Center, Dallas, Texas, United States
© Copyright 2024. All Rights Reserved by MedPath